Ezetimibe and Keppra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ezetimibe (ezetimibe) and Keppra (levetiracetam). Common drug interactions include balance disorder among females and hypertension among males.

The phase IV clinical study analyzes what interactions people have when they take Ezetimibe and Keppra. It is created by eHealthMe based on reports of 60 people who take the same drugs from the FDA, and is updated regularly.

What is Ezetimibe?

Ezetimibe has active ingredients of ezetimibe. It is often used in high blood cholesterol. eHealthMe is studying from 30,849 Ezetimibe users. Check the latest studies of Ezetimibe.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 21, 2026

60 people who take Ezetimibe and Keppra together, and have interactions are studied.

What are the common drug interactions of Ezetimibe and Keppra, by gender? *:

female:

Balance disorder
Blood pressure increased
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Chronic kidney disease
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Death
Dental caries
Dizziness
Drug ineffective
Drug intolerance (drug sensitivity)

male:

Hypertension (high blood pressure)
Dyspnoea (difficult or laboured respiration)
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Nausea (feeling of having an urge to vomit)
Pneumonia
Renal failure acute (rapid kidney dysfunction)
Renal failure chronic (long lasting kidney dysfunction)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)

What are the common drug interactions of Ezetimibe and Keppra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Drug ineffective
Dyslipidaemia (abnormal amount of lipids)

40-49:

Chronic kidney disease
Renal failure (kidney dysfunction)
Ulcer

50-59:

Obstructive sleep apnoea syndrome (frequent pauses in breathing during sleep usually accompanied by loud snoring)
Pain
Postoperative thoracic procedure complication
Pyrexia (fever)
Rhinorrhoea (watery mucus discharge from the nose)
Speech disorder
Staphylococcal infection (an infection with staphylococcus bacteria)
Type 2 diabetes mellitus
Vitamin b12 deficiency
Vitamin d deficiency

60+:

Anaemia (lack of blood)
Thrombocytopenia (decrease of platelets in blood)
Loss of consciousness
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Nausea (feeling of having an urge to vomit)
Pneumonia
Renal failure acute (rapid kidney dysfunction)
Renal failure chronic (long lasting kidney dysfunction)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)

What are the existing conditions these people have? *

Pain: 8 people, 13.33%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 10.00%
High Blood Pressure: 4 people, 6.67%
Gastric Ulcer (stomach ulcer): 4 people, 6.67%
Electroencephalogram Abnormal: 4 people, 6.67%
Diabetes: 4 people, 6.67%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 4 people, 6.67%
Lymphoedema (localized fluid retention and tissue swelling): 3 people, 5.00%
Hypersensitivity: 3 people, 5.00%
Hepatitis C: 3 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ezetimibe and Keppra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously